For the treatment of Small Vessel Indication in Coronary Arteries Concept Medical Inc. (CMI), a global leader in drug delivery devices, has received its third Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for its novel Sirolimus-Coated Balloon, Magic Touch SCB,